Role of Increased n-acetylaspartate Levels in Cancer

Journal of the National Cancer Institute

Volumn 108, Issue 6, 2016, Pages

  Zand, Behrouz ^a   Previs, Rebecca A ^a   Zacharias, Niki M ^b   Rupaimoole, Rajesha ^a   Mitamura, Takashi ^a   Nagaraja, Archana Sidalaghatta ^a   Guindani, Michele ^b   Dalton, Heather J ^a   Yang, Lifeng ^b,i   Baddour, Joelle ^b,i   Achreja, Abhinav ^b,i   Hu, Wei ^a   Pecot, Chad V ^b   Ivan, Cristina ^c   Wu, Sherry Y ^a   McCullough, Christopher R ^b   Gharpure, Kshipra M ^a   Shoshan, Einav ^a   Pradeep, Sunila ^a   Mangala, Lingegowda S ^c   Rodriguez Aguayo, Cristian ^c   Wang, Ying ^f   Nick, Alpa M ^a   Davies, Michael A ^g   Armaiz Pena, Guillermo ^a   Liu, Jinsong ^a   Lutgendorf, Susan K ^h   Baggerly, Keith A ^f   Eli, Menashe Bar ^d   Lopez Berestein, Gabriel ^b,d,e   Nagrath, Deepak ^b,i,j   Bhattacharya, Pratip K ^b   Sood, Anil K ^a,b,c,d   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Department of Cancer Systems Imaging ^*  (United States)

^c Center for RNA Interference and Non Coding RNA   (United States)

^d Departments of Cancer Biology   (United States)

^e Department of Pharmacology Experimental Therapeutics   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g Melanoma Medical Oncology   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ Laboratory for Systems Biology of Human Diseases   (United States)

^j Rice University   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID; ACYLTRANSFERASE; ASPARTIC ACID; N-ACETYLASPARTATE; NAT8 PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; MELANOMA; MOUSE; NEOPLASM; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; THYROID CANCER; TUMOR GROWTH; UTERUS CANCER; ANALOGS AND DERIVATIVES; ANIMAL; CANCER GRADING; CELL SURVIVAL; CYSTADENOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KAPLAN MEIER METHOD; METABOLISM; OVARY; OVARY TUMOR; PATHOLOGY; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

ACETYLTRANSFERASES; ANIMALS; APOPTOSIS; ASPARTIC ACID; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; NEOPLASM GRADING; OVARIAN NEOPLASMS; OVARY; TANDEM MASS SPECTROMETRY;

EID: 84977070436     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv426     Document Type: Article

References (39)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5):646-674.
2. Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309-314.
3. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism. 2008;7(1):11-20.
4. Sreekumar A, Poisson LM, Rajendiran TM, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457(7231):910-914.
5. Losman JA, Looper RE, Koivunen P, et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science. 2013;339(6127):1621-1625.
6. Vander Heiden MG, Locasale JW, Swanson KD, et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science. 2010;329(5998):1492-1499.
7. Possemato R, Marks KM, Shaul YD, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476(7360):346-350.
8. Salimian Rizi B, Caneba C, Nowicka A, et al. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells. Cancer Res. 2015;75(2):456-471.
9. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479-6483.
10. Son J, Lyssiotis CA, Ying H, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496(7443):101-105.
11. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81(16):6656-6667.
12. Weiner J 3rd, Parida SK, Maertzdorf J, et al. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PloS One. 2012;7(7):e40221.
13. Lawton KA, Berger A, Mitchell M, et al. Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;9(4):383-397.
14. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform. 2010;2(1):9.
15. Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer. New Engl J Med. 2008;359(25):2641-2650.
16. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939-944.
17. Li L, Price JE, Fan D, Zhang RD, Bucana CD, Fidler IJ. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst. 1989;81(18):1406-1412.
18. Lu C, Han HD, Mangala LS, et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010;18(2):185-197.
19. Landen CN Jr, Lu C, Han LY, et al. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. J Natl Cancer Inst. 2006;98(21):1558-1570.
20. Merritt WM, Lin YG, Spannuth WA, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst. 2008;100(5):359-372.
21. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440-9445.
22. Tothill RW, Tinker AV, George J, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14(16):5198-5208.
23. Bogunovic D, O'Neill DW, Belitskaya-Levy I, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci U S A. 2009;106(48):20429-20434.
24. Jonsson G, Busch C, Knappskog S, et al. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res. 2010;16(13):3356-3367.
25. Grambsch PM, Therneau TM. Proportional Hazards Tests and Diagnostics Based on Weighted Residuals. Biometrika. 1994;81(3):515-526.
26. Caneba CA, Yang L, Baddour J, et al. Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells. Cell Death Dis. 2014;5:e1302.
27. Yang L, Moss T, Mangala LS, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol. 2014;10:728.
28. Komurov K, Dursun S, Erdin S, Ram PT. NetWalker: A contextual network analysis tool for functional genomics. BMC Genomics. 2012;13:282.
29. Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem. 1957;224(1):41-45.
30. Tallan HH, Moore S, Stein WH. Studies on the free amino acids and related compounds in the tissues of the cat. J Biol Chem. 1954;211(2):927-939.
31. Ariyannur PS, Moffett JR, Manickam P, et al. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Res. 2010;1335:1-13.
32. Wiame E, Tyteca D, Pierrot N, et al. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J. 2010;425(1):127-136.
33. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007;81(2):89-131.
34. Stadlbauer A, Hammen T, Buchfelder M, et al. Differences in metabolism of fiber tract alterations in gliomas: A combined fiber density mapping and magnetic resonance spectroscopic imaging study. Neurosurgery. 2012;71(2):454-463.
35. Li Y, Lupo JM, Parvataneni R, et al. Survival analysis in patients with newly diagnosed glioblastoma using pre-and postradiotherapy MR spectroscopic imaging. Neuro-oncology. 2013;15(5):607-617.
36. Yao X, Zeng M, Wang H, Fei S, Rao S, Ji Y. Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results. Radiol Med. 2012;117(5):780-788.
37. Fong MY, McDunn J, Kakar SS. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PloS One. 2011;6(5):e19963.
38. Ben Sellem D, Elbayed K, Neuville A, et al. Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy. J Oncol. 2011;2011:174019.
39. Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609-615.